Physician profile
Dwayne Gorman
NPI 1033368295
$1,330.96
in general payments reported to CMS, 2019-2025
27 companies · $218 in 2025
The $218 reported for 2025 was more than what 76% of Pediatrics providers received nationally (typical 2025 total: $96.93).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $14.13 · 2020: $115 · 2021: $320 · 2022: $249 · 2023: $300 · 2024: $115 · 2025: $218.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $633.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $632.93 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Cranial Technologies, INC | $120.55 | 2020-2023 | Doc Band |
| Amgen INC. | $115.97 | 2021-2025 | Krystexxa, Repatha, Otezla |
| Abbvie INC. | $110.86 | 2020-2025 | |
| Otsuka America Pharmaceutical, INC. | $99.18 | 2023-2024 | Rexulti |
| Novartis Pharmaceuticals Corporation | $95.46 | 2022-2023 | |
| Abbott Laboratories | $88.34 | 2019-2025 | Proclaim, Freestyle Libre 3 |
| Pfizer INC. | $86.88 | 2023-2025 | |
| Glaxosmithkline, LLC. | $80.05 | 2022-2025 | Bexsero, Shingrix |
| Xeris Pharmaceuticals, INC. | $66.60 | 2022-2023 | Gvoke Hypopen |
| Lilly USA, LLC | $51.89 | 2021-2023 | Jardiance |
| Grifols USA, LLC | $44.45 | 2021 | |
| Bayer Healthcare Pharmaceuticals INC. | $43.13 | 2021-2022 | |
| Sunovion Pharmaceuticals INC. | $42.85 | 2021 | |
| Nestle Healthcare Nutrition INC. | $34.85 | 2021-2022 | |
| Novo Nordisk INC | $31.48 | 2020-2023 | Rybelsus, Ozempic |
Show all 27 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Janssen Pharmaceuticals, INC | $30.82 | 2021-2023 | Spravato |
| Silk Road Medical, INC. | $27.94 | 2020 | |
| Sanofi Pasteur INC. | $22.90 | 2022 | |
| Kestra Medical Technology Services, INC. | $19.89 | 2025 | Assure Wcd |
| Biohaven Pharmaceuticals, INC. | $18.54 | 2020 | |
| Optinose US, INC. | $16.66 | 2021 | |
| Almatica Pharma LLC | $16.13 | 2021 | |
| Neotract INC. | $14.37 | 2020 | |
| Merck Sharp & Dohme LLC | $13.01 | 2021 | |
| Dexcom, INC. | $12.90 | 2021 | |
| Lucid Diagnostics INC. | $12.88 | 2022 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $12.38 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Dwayne Gorman listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.